SUBSCRIBE
SUBSCRIBE
News   Drug Development

FDA Advisers Vote Against Procter & Gamble’s Female Sex Drug

October 19, 2005 | 
1 min read
Procter & Gamble Co.'s testosterone patch for boosting female sex drive needs longer-term testing for serious side effects before it can win approval, a U.S. advisory panel unanimously ruled on Thursday.
Clinical research Phase 3 FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Business decision concept with a businessman standing on a huge question mark. Symbol of the future, opportunities, planning, vision. Vector illustration
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
From Grants to Family Offices: Building a Unified Financing Strategy in Biotech
March 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Illustration of a yellow envelope on a blue background with a read warning symbol
Supply chain
FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP-1s
March 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor